Robert Chen
Impact in
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
- Oncology top 0.5%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lymphoma Diagnosis and Treatment 67
- Oncology 56
- Viral-associated cancers and disorders 21
- CAR-T cell therapy research 16
- HER2/EGFR in Cancer Research 14
- Co-authors
- Ajay K. Gopal (14 shared papers)Scott E. Smith (9 shared papers)Craig H. Moskowitz (8 shared papers)Joseph D. Rosenblatt (7 shared papers)Stephen M. Ansell (8 shared papers)Anas Younes (8 shared papers)Joseph M. Connors (7 shared papers)Emily K. Larsen (6 shared papers)
- Journals
- Blood (35 papers)Biology of Blood and Marrow Transplantation (6 papers)Journal of Clinical Oncology (3 papers)Clinical Cancer Research (2 papers)Journal of Hematology & Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Robert Chen
79 papers receiving 4.9k citations
Robert Chen's Hit Papers
Peers
Comparison fields: 5 of 85
- Pathology and Forensic Medicine 3.1k
- Oncology 3.1k
- Genetics 849
- Neurology 973
- Immunology 902
Countries citing papers authored by Robert Chen
This map shows the geographic impact of Robert Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Chen more than expected).
Fields of papers citing papers by Robert Chen
This network shows the impact of papers produced by Robert Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Chen. The network helps show where Robert Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma Hit paper breakdown → | 2012 | 1071 |
| 2 | Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma Hit paper breakdown → | 2017 | 721 |
| 3 | 2016 | 282 | |
| 4 | 2019 | 233 | |
| 5 | 2017 | 213 | |
| 6 | 2015 | 173 | |
| 7 | 2014 | 161 | |
| 8 | 2014 | 138 | |
| 9 | 2020 | 115 | |
| 10 | 2012 | 114 | |
| 11 | 2000 | 111 | |
| 12 | 2015 | 99 | |
| 13 | 2015 | 98 | |
| 14 | 2012 | 97 | |
| 15 | 2019 | 85 | |
| 16 | 2016 | 79 | |
| 17 | 2013 | 79 | |
| 18 | 2019 | 67 | |
| 19 | 2013 | 67 | |
| 20 | 2017 | 67 |
About Robert Chen
Robert Chen is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 80 papers that have together received 5.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (67 papers), Viral-associated cancers and disorders (21 papers), CAR-T cell therapy research (16 papers), Chronic Lymphocytic Leukemia Research (16 papers), HER2/EGFR in Cancer Research (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), CNS Lymphoma Diagnosis and Treatment (8 papers) and Lung Cancer Treatments and Mutations (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.1k citations), Oncology (3.1k citations), Genetics (849 citations), Neurology (973 citations) and Immunology (902 citations). Robert Chen has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Ajay K. Gopal, Scott E. Smith, Craig H. Moskowitz, Joseph D. Rosenblatt, Stephen M. Ansell, Anas Younes, Joseph M. Connors, Emily K. Larsen, Andreas Engert and Andres Forero‐Torres. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Clinical Cancer Research and Journal of Hematology & Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.